Abstract Hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality but lacks effective treatments thus far. Although the emergence of immune checkpoint inhibitors in recent years has shed light on the treatment of HCC. a considerable number of patients are still unable to achieve durable and ideal clinical benefits. Therefore. https://www.benefitlabacademy.com/product-category/massachusetts/